The Asia Pacific Minimally Invasive Surgical Instruments Market was valued at $6620.5 Million in 2024 and projected to reach to $11120 Million by 2029, representing a compound annual growth rate of 10.9%. Asia Pacific's minimally invasive surgical instruments market is positioned for exceptional growth, driven by converging factors including rising healthcare expenditures, an aging demographic profile, and increasing patient preference for less invasive procedures.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific's minimally invasive surgical instruments market grows at 10.9% CAGR, significantly exceeding the global average of 9.5%, reflecting accelerated adoption across the region.
Rapid demographic shifts in Asia Pacific, particularly in Japan, China, and South Korea, are increasing surgical procedure volumes and demand for advanced MIS technologies.
Governments across Asia Pacific are substantially increasing healthcare infrastructure spending, enabling hospitals and surgical centers to adopt cutting-edge minimally invasive instruments.
The region's market is projected to grow from $6,620.5 million in 2024 to $11,120 million by 2029, representing a 68% increase in market value over five years.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | ROBOTIC INSTRUMENTS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.5% from 2024 to 2029 |
| Largest Segment | NON-ROBOTIC SURGERY (Technology) |
| Market Size Base Year (Billions) | ~USD 31.7 (2024) |
| Revenue Forecast (Billions) | ~USD 49.9 (2029) |
| Segments Covered | Product, Type, Technology, Type Of Surgery, End User |
5 segment dimensions are covered across the global market.
| Country | 2025 size (native) |
|---|---|
| China | USD 882.2 Million |
| Japan | USD 536.4 Million |
| India | USD 500.6 Million |
| Rest Of Asia Pacific | USD 571.9 Million |
In 2024, Asia Pacific's minimally invasive surgical instruments market is valued at $6,620.5 million, with expectations to reach $11,120 million by 2029.
Asia Pacific's minimally invasive surgical instruments market is projected to grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2029.
Key growth drivers in Asia Pacific include China, Japan, India, and South Korea, where rising healthcare investments and surgical procedure volumes are accelerating MIS adoption.
Asia Pacific's market growth is fueled by improving healthcare infrastructure, aging populations, rising disposable incomes, and increasing patient preference for procedures with shorter recovery times.
Asia Pacific's 10.9% CAGR exceeds the global average of 9.5%, making the region a critical growth engine for the worldwide minimally invasive surgical instruments market.
The objective of the study is analyzing the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies’ developments such as product launch, approval, acquisition, agreement and expansion of the leading players, the competitive landscape of the minimally invasive surgical instruments market to analyzes market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY NAME |
DESIGNATION |
|
Medtronic PLC (US) |
Marketing Manager |
|
Johnson & Johnson (US) |
Senior Product Manager |
|
Intuitive Surgical Inc. (US) |
Marketing Manager |
Both top-down and bottom-up approaches were used to estimate and validate the home healthcare market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Minimally invasive surgery (MIS) is a surgical procedure done in a manner that causes little to no trauma or injury to a patient. MIS is executed through a cannula using lasers, endoscopes or laparoscopes. MIS involves less bleeding, smaller amounts of anesthesia, less pain, and minimal scarring than other procedures. The surgical instruments used to make minute incisions in the body and perform MIS procedures are minimally invasive.
MarketsandMarkets offers the following customizations for this market report
Full forecast, segment splits, and company analysis for all Minimally Invasive Surgical Instruments Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report